Lu Y - Search Results

1

Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion.

Chaganty BKR, Qiu S, Gest A, Lu Y, Ivan C, Calin GA, Weiner LM, Fan Z. Chaganty BKR, et al. Among authors: lu y. Cancer Lett. 2018 Aug 28;430:47-56. doi: 10.1016/j.canlet.2018.05.009. Epub 2018 May 8. Cancer Lett. 2018. PMID: 29746929 Free PMC article.

2

A novel single amino acid deletion caspase-8 mutant in cancer cells that lost proapoptotic activity.

Liu B, Peng D, Lu Y, Jin W, Fan Z. Liu B, et al. Among authors: lu y. J Biol Chem. 2002 Aug 16;277(33):30159-64. doi: 10.1074/jbc.M203566200. Epub 2002 Jun 7. J Biol Chem. 2002. PMID: 12055196 Free article.

3

HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.

Knuefermann C, Lu Y, Liu B, Jin W, Liang K, Wu L, Schmidt M, Mills GB, Mendelsohn J, Fan Z. Knuefermann C, et al. Among authors: lu y. Oncogene. 2003 May 22;22(21):3205-12. doi: 10.1038/sj.onc.1206394. Oncogene. 2003. PMID: 12761490

4

Sensitization of breast cancer cells to radiation by trastuzumab.

Liang K, Lu Y, Jin W, Ang KK, Milas L, Fan Z. Liang K, et al. Among authors: lu y. Mol Cancer Ther. 2003 Nov;2(11):1113-20. Mol Cancer Ther. 2003. PMID: 14617784

5

The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression.

Luwor RB, Lu Y, Li X, Mendelsohn J, Fan Z. Luwor RB, et al. Among authors: lu y. Oncogene. 2005 Jun 23;24(27):4433-41. doi: 10.1038/sj.onc.1208625. Oncogene. 2005. PMID: 15806152

6

Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells.

Li X, Lu Y, Liang K, Liu B, Fan Z. Li X, et al. Among authors: lu y. Breast Cancer Res. 2005;7(5):R589-97. doi: 10.1186/bcr1259. Epub 2005 May 24. Breast Cancer Res. 2005. PMID: 16168102 Free PMC article.

7

Autophosphorylation of Akt at threonine 72 and serine 246. A potential mechanism of regulation of Akt kinase activity.

Li X, Lu Y, Jin W, Liang K, Mills GB, Fan Z. Li X, et al. Among authors: lu y. J Biol Chem. 2006 May 12;281(19):13837-13843. doi: 10.1074/jbc.M602060200. Epub 2006 Mar 20. J Biol Chem. 2006. PMID: 16549426 Free article.

8

Differential roles of phosphoinositide-dependent protein kinase-1 and akt1 expression and phosphorylation in breast cancer cell resistance to Paclitaxel, Doxorubicin, and gemcitabine.

Liang K, Lu Y, Li X, Zeng X, Glazer RI, Mills GB, Fan Z. Liang K, et al. Among authors: lu y. Mol Pharmacol. 2006 Sep;70(3):1045-52. doi: 10.1124/mol.106.023333. Epub 2006 Jun 16. Mol Pharmacol. 2006. PMID: 16782806

9

Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer.

Adams KE, Ke S, Kwon S, Liang F, Fan Z, Lu Y, Hirschi K, Mawad ME, Barry MA, Sevick-Muraca EM. Adams KE, et al. Among authors: lu y. J Biomed Opt. 2007 Mar-Apr;12(2):024017. doi: 10.1117/1.2717137. J Biomed Opt. 2007. PMID: 17477732 Free article.

10

Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab.

Lu Y, Li X, Liang K, Luwor R, Siddik ZH, Mills GB, Mendelsohn J, Fan Z. Lu Y, et al. Cancer Res. 2007 Sep 1;67(17):8240-7. doi: 10.1158/0008-5472.CAN-07-0589. Cancer Res. 2007. PMID: 17804738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,034 results

Search Page

Filters